ci
confid
interv
ebv
epsteinbarr
viru
fev
forc
expiratori
volum
second
nnt
number
need
treat
pao
arteri
partial
pressur
oxygen
rr
rel
risk
sar
sever
acut
respiratori
syndrom
tradit
teach
suggest
corticosteroid
avoid
acut
infecti
episod
fear
compromis
immun
respons
howev
outcom
benefit
shown
steroid
administr
earli
septic
shock
impli
paranoia
may
misplac
therefor
perform
systemat
review
literatur
identifi
current
strength
evid
use
corticosteroid
specifi
infect
make
appropri
grade
recommend
tradit
teach
suggest
corticosteroid
impair
abil
bodi
fight
infect
may
prove
catastroph
appropri
antibiot
chosen
recent
year
howev
earli
use
steroid
therapi
becom
progress
establish
wide
rang
infect
condit
includ
septic
shock
sever
system
manifest
thu
decid
conduct
systemat
review
literatur
identifi
current
strength
evid
use
corticosteroid
specifi
infect
make
appropri
grade
recommend
cochran
databas
systemat
review
databas
abstract
review
effect
dare
cochran
central
regist
control
trial
central
issu
search
use
medic
subject
head
mesh
steroid
glucocorticoid
adren
cortex
hormon
viru
diseas
bacteri
infect
mycos
addit
phase
cochran
highli
sensit
strategi
randomis
control
trial
steroid
search
tabl
search
term
specif
clinic
entiti
utilis
medlin
embas
systemat
review
publish
sinc
form
mainstay
analysi
trial
publish
recent
consid
review
also
includ
infect
prior
review
origin
articl
summaris
abstract
thu
obtain
scan
relev
origin
paper
retriev
specif
clinic
entiti
review
order
strength
evid
proceed
metaanalys
multipl
wellcontrol
trial
singl
small
studi
case
report
tabl
show
system
use
grade
level
evid
consequ
level
recommend
use
corticosteroid
specifi
infect
use
steroid
septic
shock
subject
controversi
five
decad
lack
benefit
report
two
larg
multicentr
randomis
trial
prompt
two
metaanalys
publish
recommend
short
cours
high
dose
steroid
longer
use
patient
sepsi
syndrom
subsequ
studi
sicker
septic
popul
howev
report
either
surviv
benefit
reduct
catecholamin
requir
longer
cours
day
lower
stress
dose
corticosteroid
mg
hydrocortison
daili
equival
strateg
shift
adren
replac
dose
albeit
dose
chosen
still
gener
supraphysiolog
level
aros
recognit
rel
adren
insuffici
common
phenomenon
sepsi
poor
prognost
factor
rebound
increas
plasma
cytokin
level
three
day
prompt
recommend
steroid
dose
tail
rather
stop
abruptli
view
recent
cochran
systemat
review
accompani
public
reexamin
use
corticosteroid
septic
shock
although
review
clinic
review
systemat
review
corticosteroid
use
infect
overal
outcom
benefit
subgroup
analysi
trial
use
low
dose
steroid
show
signific
reduct
day
mortal
rel
risk
rr
confid
interv
ci
hospit
mortal
rr
ci
shock
revers
day
rr
ci
day
rr
ci
largest
studi
contribut
subgroup
analysi
worthi
individu
consider
although
contribut
weight
review
trial
demonstr
signific
mortal
reduct
subgroup
patient
show
subnorm
rise
plasma
cortisol
nmoll
respons
stimul
tetracosactrin
synthet
adrenocorticotrop
hormon
acth
sinc
argu
septic
shock
patient
receiv
corticosteroid
regardless
tetracosactrin
respons
ground
lack
harm
wherea
other
counsel
caution
view
risk
potenti
advers
event
myopathi
larg
multicentr
european
studi
corticu
shortli
conclud
hope
provid
definit
data
believ
steroid
use
tetracosactrin
nonrespond
low
dose
mg
hydrocortison
equivalentday
day
given
patient
subnorm
cortisol
respons
nmoll
follow
tetracosactrin
grade
evid
grade
recommend
b
hydrocortison
start
pend
laboratori
result
discontinu
rise
cortisol
level
follow
tetracosactrin
exce
seven
day
cours
dose
corticosteroid
tail
five
seven
day
grade
evid
iv
grade
recommend
e
recent
systemat
review
perform
perprotocol
analysi
enrol
patient
age
group
corticosteroid
therapi
consist
either
dexamethason
mgkg
hydrocortison
prednisolon
combin
mortal
rate
without
steroid
therapi
respect
provid
number
need
treat
nnt
save
one
life
increas
subset
children
steroid
group
mortal
placebo
fell
adult
patient
steroid
placebo
author
exercis
caution
adult
data
analysi
due
methodolog
concern
one
major
trial
includ
caus
organ
appear
import
determin
outcom
benefit
steroid
signific
benefit
found
treat
streptococcu
pneumonia
speci
haemophilu
influenza
though
statist
signific
also
achiev
neisseria
meningitid
infect
hear
loss
significantli
reduc
steroid
control
provid
nnt
nnt
lower
children
steroid
control
benefit
seen
regardless
caus
organ
longterm
neurolog
sequela
reduc
overal
achiev
signific
age
group
organ
subset
analys
perform
nonsignific
increas
gastrointestin
bleed
note
otherwis
associ
advers
effect
greater
risk
reduct
occur
steroid
given
start
antibiot
basi
review
author
recommend
regimen
dexamethason
mgkg
daili
four
day
start
prefer
antibiot
therapi
recent
publish
studi
adult
patient
bacteri
mening
add
support
find
randomis
receiv
dexamethason
show
absolut
reduct
death
disabl
sever
moder
overal
nnt
pneumonia
subgroup
nnt
statist
signific
howev
achiev
reduct
neurolog
sequela
includ
hear
loss
author
recommend
dose
mg
dexamethason
qd
hour
start
antibiot
therapi
though
reserv
rais
regimen
mening
caus
pneumococcu
set
sepsi
popul
set
may
import
larg
randomis
trial
paediatr
mening
develop
countri
late
present
diseas
high
level
resist
avail
antimicrobi
higher
preval
chronic
diseas
malnutrit
demonstr
effect
either
surviv
neurolog
sequela
dexamethason
mg
qd
equival
given
hour
prefer
commenc
prior
antibiot
therapi
grade
evid
grade
recommend
patient
pneumocysti
jiroveci
pneumonia
may
suffer
deterior
pulmonari
function
initi
antimicrobi
efficaci
adjunct
corticosteroid
therapi
avoid
complic
investig
lead
consensu
statement
recommend
use
hiv
posit
adolesc
adult
moder
sever
diseas
arteri
partial
pressur
oxygen
pao
kpa
alveolararteri
gradient
kpa
steroid
start
prefer
within
hour
admiss
randomis
nonblind
trial
prednisolon
versu
placebo
hiv
posit
patient
mainli
confirm
pneumocysti
pneumonia
reveal
signific
mortal
reduct
day
likelihood
combin
endpoint
respiratori
failur
defin
death
mechan
ventil
pao
fio
ratio
kpa
time
common
among
elig
nonsteroid
treat
patient
nnt
gain
benefit
advers
effect
includ
signific
increas
herp
reactiv
possibl
oral
thrush
prednisolon
mg
twice
daili
day
mg
daili
day
mg
daili
day
given
adult
patient
pao
kpa
alveolararteri
gradient
kpa
grade
evid
grade
recommend
small
recent
publish
multicentr
trial
patient
sever
communityacquir
pneumonia
randomis
receiv
hydrocortison
mg
bolu
follow
mgh
infus
day
show
signific
improv
ga
exchang
resolut
organ
failur
reduct
hospit
stay
hydrocortison
mg
bolu
follow
mgh
infus
day
may
consid
sever
communityacquir
pneumonia
grade
evid
ii
grade
recommend
c
corticosteroid
therapi
methylprednisolon
hydrocortison
routin
use
outbreak
coronavirusassoci
sever
acut
respiratori
syndrom
sar
follow
earli
anecdot
report
benefit
rapid
emerg
syndrom
prevent
establish
randomis
control
trial
two
subsequ
retrospect
review
two
differ
hong
kong
hospit
produc
confict
result
one
claim
greater
benefit
initi
therapi
puls
steroid
methylprednisolon
mgday
term
supplement
oxygen
requir
better
radiograph
outcom
though
need
intens
care
unit
admiss
mechan
ventil
mortal
rate
similar
studi
howev
report
corticosteroid
use
associ
doubl
advers
outcom
versu
increas
risk
either
intens
care
unit
admiss
mortal
independ
age
diseas
sever
steroid
recommend
treatment
sarsrel
pneumonia
grade
evid
v
grade
recommend
e
steroid
use
children
bronchiol
ventil
grade
evid
ii
grade
recommend
c
steroid
given
children
mild
bronchiol
viral
wheez
present
outpati
best
regimen
yet
undetermin
grade
evid
ii
grade
recommend
c
steroid
administ
children
croup
optim
dose
rout
yet
defin
grade
evid
grade
recommend
tubercul
mening
carri
high
mortal
steroid
use
adjunct
treatment
sinc
yet
even
mortal
still
around
neurolog
sequela
common
survivor
review
six
studi
total
patient
mild
sever
diseas
show
mortal
reduct
steroid
rr
ci
nnt
analysi
age
suggest
risk
reduct
year
old
although
total
number
adult
recruit
small
mortal
mild
diseas
rare
allow
analysi
hiv
statu
record
trial
analys
consider
heterogen
record
advers
event
neurolog
sequela
studi
gave
evid
optim
treatment
conceal
funnel
plot
suggest
public
bia
henc
firm
recommend
could
given
without
evid
recent
trial
involv
patient
age
vietnam
definit
probabl
tubercul
mening
randomis
receiv
four
week
taper
intraven
dexamethason
follow
four
week
oral
therapi
start
mgkg
nonmild
diseas
mgkg
mild
case
nine
month
steroid
group
show
absolut
risk
reduct
mortal
placebo
nnt
signific
reduct
death
sever
disabl
combin
perhap
studi
power
way
disabl
measur
hiv
infect
associ
higher
mortal
effect
steroid
seen
subgroup
advers
event
lower
steroid
group
particularli
led
chang
antitubercul
therapi
druginduc
hepat
chang
therapi
associ
death
possibl
mechan
mortal
reduct
effect
steroid
dexamethason
taper
four
week
mgkg
mgkg
depend
upon
sever
administ
tubercul
mening
grade
evid
grade
recommend
review
four
trial
involv
patient
show
trend
reduc
mortal
persist
diseas
statist
signific
reduc
mortal
reach
tubercul
effus
rr
ci
signific
lost
intentiontotreat
analysi
subgroup
analysi
hiv
posit
individu
show
signific
result
recent
randomis
trial
south
african
patient
stratifi
patient
diseas
type
name
constrict
effus
drainag
effus
conserv
manag
effect
prednisolon
mortal
function
statu
need
repeat
pericardiocentesi
studi
prednisolon
group
show
trend
toward
improv
overal
surviv
significantli
decreas
composit
endpoint
death
advers
outcom
nnt
mainli
reduc
need
pericardectomi
associ
mortal
upon
correct
age
gender
death
tubercul
pericard
significantli
reduc
signific
effect
function
statu
year
prednisolon
taper
mg
daili
adult
dose
week
given
tubercul
pericard
grade
evid
grade
recommend
three
small
trial
investig
use
steroid
tubercul
pleurisi
analys
systemat
review
scale
measur
mortal
thu
steroid
recommend
basi
signific
reach
reduct
symptomatolog
acut
phase
reduc
pleural
sequela
recent
trial
hiv
posit
patient
pleural
tuberculosi
show
signific
reduct
mortal
nonsignific
increas
recurr
higher
rate
kaposi
sarcoma
steroidtr
group
henc
yet
recommend
use
steroid
group
evid
still
lack
nonhiv
infect
individu
steroid
given
tubercul
pleurisi
hiv
posit
patient
grade
evid
grade
recommend
b
steroid
yet
recommend
tubercul
pleurisi
nonhiv
posit
patient
grade
evid
ii
grade
recommend
c
variou
clinic
indic
improv
use
steroid
pulmonari
tuberculosi
accord
review
studi
signific
improv
seen
time
defervesc
weight
gain
hospit
stay
inflammatori
marker
xray
appear
infiltr
cavit
faster
resolv
sputum
smear
cultur
posit
alter
heterogen
studi
enabl
review
perform
overal
statist
analysi
born
mind
howev
studi
predat
conduct
advent
rifampicin
result
thu
treat
cautious
system
steroid
therapi
also
suggest
improv
bronchoscop
radiograph
resolut
tubercul
bronchial
obstruct
children
randomis
studi
patient
recent
studi
hivassoci
tuberculosi
howev
suggest
benefit
prednisolon
therapi
immun
activ
cell
count
outweigh
risk
advers
event
transient
increas
hiv
rna
level
worsen
underli
hypertens
fluid
retent
hyperglycemia
steroid
may
consid
patient
pulmonari
tuberculosi
particularli
extens
diseas
hivposit
patient
grade
evid
ii
grade
recommend
c
ten
random
control
trial
total
patient
differ
regimen
system
steroid
exacerb
chronic
obstruct
pulmonari
diseas
recent
analys
primari
endpoint
treatment
failur
defin
need
extra
repeat
treatment
exacerb
mortal
steroid
reduc
risk
odd
ratio
ci
nnt
differ
seen
mortal
improv
breathless
measur
forc
expiratori
volum
second
fev
arteri
blood
ga
test
hospit
stay
reduc
possibl
due
heterogen
discharg
polici
comorbid
advers
event
like
number
need
harm
overal
hyperglycaemia
review
confirm
reduct
treatment
failur
also
reduc
length
hospit
stay
review
suggest
two
week
steroid
therapi
effect
eight
less
associ
infect
risk
longterm
inhal
steroid
also
reduc
risk
acut
exacerb
subgroup
patient
fev
rr
ci
short
cours
oral
steroid
given
exacerb
chronic
obstruct
pulmonari
diseas
may
form
mg
prednisolon
daili
day
grade
evid
ii
grade
recommend
c
review
trial
inhal
steroid
cystic
fibrosi
find
differ
lung
function
test
number
day
treatment
antibiot
inhal
steroid
administ
routin
cystic
fibrosi
patient
grade
evid
ii
grade
recommend
c
systemat
review
found
adequ
trial
steroid
therapi
prior
involv
patient
pretreat
four
six
week
steroid
show
improv
clearanc
marker
infect
hepat
e
antigen
hepat
b
dna
howev
differ
mortal
hepat
b
surfac
antigen
hepat
b
e
antibodi
liver
histolog
qualiti
life
advers
event
equal
distribut
author
conclud
recommend
would
requir
improv
clinic
outcom
seen
steroid
use
pretreat
chronic
hepat
b
grade
evid
ii
grade
recommend
c
review
found
eight
randomis
trial
examin
corticosteroid
chronic
hepat
c
protocol
patient
group
show
signific
heterogen
use
steroid
alon
combin
interferon
comparison
placebo
interferon
effect
allcaus
liverrel
mortal
virolog
respons
biochemistri
liver
biopsi
find
one
trial
report
signific
reduct
sideeffect
interferon
concurr
steroid
use
steroid
use
treatment
chronic
hepat
c
grade
evid
ii
grade
recommend
c
trial
involv
patient
acut
viral
hepat
studi
methylprednisolon
taper
mg
daili
week
benefit
steroid
inde
nonsignific
trend
toward
increas
mortal
hospit
stay
time
symptom
resolut
biochem
marker
unaffect
steroid
use
treatment
acut
viral
hepat
grade
evid
ii
grade
recommend
b
review
consid
trial
patient
improv
recoveri
motor
function
presenc
synkinesi
autonom
dysfunct
result
odd
previous
publish
analys
recommend
steroid
author
note
prior
analys
includ
studi
loss
follow
signific
lost
exclus
trial
steroid
use
treat
bell
palsi
grade
evid
ii
grade
recommend
c
adjunct
steroid
use
improv
mortal
neurolog
sequela
common
review
found
two
adequ
trial
total
patient
mortal
improv
dexamethason
trial
far
small
howev
exclud
effect
one
studi
suggest
steroid
use
increas
time
recoveri
coma
therefor
may
detriment
henc
recommend
thu
far
small
trial
steroid
treat
nephrot
syndrom
result
plasmodium
malaria
found
reduct
proteinuria
steroid
use
treat
cerebr
malaria
grade
evid
ii
grade
recommend
c
steroid
use
treat
nephrot
syndrom
secondari
malaria
grade
evid
ii
grade
recommend
c
case
control
studi
blood
cultur
confirm
sever
typhoid
case
papua
new
guinea
found
mg
hydrocortison
hourli
dose
improv
mortal
find
contrast
earlier
randomis
studi
trial
patient
jakarta
examin
dexamethason
mgkg
follow
mgkg
dose
gave
case
fatal
steroid
treatment
versu
placebo
nnt
investig
later
publish
case
control
seri
patient
similar
mortal
reduct
partial
blind
trial
steroid
adjunct
surgeri
typhoid
perfor
gave
similar
mortal
reduct
trial
number
small
given
dramat
reduct
mortal
steroid
recommend
higher
dose
sever
typhoid
particularli
shock
delirium
coma
exclus
bacteri
mening
see
steroid
use
sever
typhoid
grade
evid
ii
grade
recommend
c
effect
adjuv
dexamethason
compar
antibiot
alon
studi
one
random
control
trial
children
age
month
year
diagnosi
septic
arthriti
given
either
placebo
mgkg
dexamethason
four
day
diagnosi
steroid
group
significantli
less
joint
dysfunct
time
finish
treatment
versu
nnt
month
versu
nnt
month
follow
versu
nnt
detail
given
advers
event
relat
steroid
use
residu
dysfunct
seem
like
staphylococcu
aureu
infect
trial
number
preclud
subgroup
analysi
dexamethason
mgkg
day
given
haematogen
septic
arthriti
grade
evid
ii
grade
recommend
c
absenc
specif
antivir
agent
high
dose
glucocorticoid
fluid
rehydr
use
treat
dengu
shock
syndrom
steroid
use
support
earli
studi
patient
find
confirm
recent
trial
case
fatal
differ
amongst
children
randomis
studi
one
caveat
observ
mortal
rate
lower
expect
thu
underpow
trial
leav
possibl
steroid
effect
steroid
yet
recommend
basi
dengu
shock
syndrom
steroid
use
dengu
shock
syndrom
grade
evid
ii
grade
recommend
c
one
recent
trial
singl
dose
dexamethason
mgkg
administ
adolesc
suspect
epsteinbarr
viru
ebv
pharyng
gave
improv
pain
score
visual
analogu
scale
hour
thereaft
earlier
trial
combin
acyclovir
prednisolon
effect
either
durat
clinic
symptom
develop
ebvspecif
cellular
immun
nonrandom
studi
patient
impend
airway
obstruct
demonstr
rapid
clinic
improv
steroid
although
none
control
group
actual
develop
airway
obstruct
steroid
may
benefit
infecti
mononucleosi
respiratori
compromis
sever
pharyng
oedema
grade
evid
ii
grade
recommend
c
review
found
one
random
trial
steroid
use
whoop
cough
infant
seven
trial
particip
lead
nonsignific
effect
cough
reduct
durat
hospit
stay
steroid
administ
whoop
cough
infant
grade
evid
ii
grade
recommend
c
steroid
recommend
new
nerv
damag
leprosi
recommend
howev
base
expert
opinion
recent
review
highlight
lack
control
trial
case
seri
demonstr
improv
nerv
function
ambulatori
patient
mg
prednisolon
daili
week
recent
trial
prophylact
mg
prednisolon
daili
prevent
revers
reaction
treatment
result
signific
reduct
nerv
damag
month
statist
signific
chang
month
albeit
rel
decreas
trial
higher
dose
prednisolon
taper
mg
daili
week
establish
impair
nerv
function
show
greater
likelihood
improv
compar
placebo
among
peopl
enrol
prednisolon
mg
daili
week
use
treat
revers
reaction
caus
new
nerv
function
impair
leprosi
grade
evid
ii
grade
recommend
c
steroid
use
prophylaxi
leprosi
revers
reaction
grade
evid
ii
grade
recommend
c
steroid
use
treat
establish
impair
nerv
function
leprosi
grade
evid
ii
grade
recommend
c
onchocerca
volvulu
microfilaria
usual
treat
ivermectin
diethlycarbamazin
use
significantli
increas
chanc
reaction
lyse
microfilaria
mazzotti
reaction
compris
itch
rash
fever
tachycardia
hypotens
sometim
fatal
small
trial
patient
demonstr
cardiovascular
cutan
aspect
reaction
could
allevi
use
three
day
prednisolon
mg
three
time
daili
prednisolon
mg
daili
day
use
treat
mazzotti
reaction
grade
evid
ii
grade
recommend
c
patient
solitari
granuloma
stage
neurocysticercosi
small
trial
patient
suggest
mgkg
prednisolon
day
new
onset
seizur
well
antiepilept
medicin
may
result
higher
chanc
lesion
resolut
higher
chanc
remain
seizur
free
prednisolon
mgkg
day
use
treat
solitari
granuloma
stage
neurocysticercosi
grade
evid
ii
grade
recommend
c
present
synthesi
divers
evid
relat
steroid
use
infect
detail
consider
applic
steroid
found
conditionspecif
review
mani
cite
condit
cover
rang
wide
sever
durat
site
type
caus
organ
furthermor
dose
durat
steroid
therapi
vari
enorm
condit
clearli
illustr
steroid
use
sepsi
benefit
harm
may
accru
depend
regimen
use
mani
condit
list
limit
data
avail
obviou
need
adequ
power
trial
provid
definit
evid
benefit
harm
better
understand
steroid
modul
diseas
process
